{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:35:12Z","timestamp":1783542912932,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007154","name":"Wake Forest University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007154","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose of Review<\/jats:title>\n            <jats:p>Present an updated overview of the prevention, diagnosis, and management of infective endocarditis in adult patients with congenital heart disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent Findings<\/jats:title>\n            <jats:p>Care for patients with infective endocarditis is changing in the areas of specialized teams, diagnostics, and prevention. Endocarditis teams should be involved in the care of ACHD patients. The 2023 Duke Criteria for Infective Endocarditis and the 2023 European Society of Cardiology Guidelines have updated the criteria for diagnosis including new major criteria such as CT and positron emission computed tomography with 18F-fluorodeoxyglucose (FDG) scans. Immunological, PCR, and nucleic acid-based tests are now acceptable means to isolate infective organisms. Clindamycin is no longer recommended for antibiotic prophylaxis due to resistance and side effect profile. Special considerations for antibiotic prophylaxis and management must be made for specific congenital heart diseases in adulthood and pregnant ACHD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Infective endocarditis (IE), a potentially devastating clinical entity, is a feared threat to the health of adults with congenital heart disease (ACHD). IE needs a systematic approach for its prevention, early diagnosis and management with a multidisciplinary IE team\u2019s involvement. There have been changes in the diagnostics and management of IE, which is reflected in updated diagnostic criteria. Timely blood cultures and imaging continue to be the mainstay of diagnosis, however the timing of blood cultures, microbiological testing, and types of diagnostic imaging such as the positron emission computed tomography with 18F-fluorodeoxyglucose (FDG) scan are new. Bicuspid aortic valves, ventricular septal defects, transcatheter pulmonary valve replacements, and tetralogy of Fallot are diagnoses at higher risk for IE in the ACHD population. The following article will focus on the preventive strategies, in addition to novel diagnostic and therapeutic approaches of IE in ACHD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11886-024-02103-9","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T08:02:27Z","timestamp":1725004947000},"page":"1031-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endocarditis in Adult Congenital Heart Disease Patients: Prevention, Recognition, and Management"],"prefix":"10.1007","volume":"26","author":[{"given":"Victoria","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Baraona","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Whitlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge R.","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"3","key":"2103_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0510","volume":"83","author":"MT Mills","year":"2022","unstructured":"Mills MT, Al-Mohammad A, Warriner DR. Changes and advances in the field of infective endocarditis. Br J Hosp Med (Lond). 2022;83(3):1\u201311.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"26","key":"2103_CR2","first-page":"2048","volume":"38","author":"JM Kuijpers","year":"2017","unstructured":"Kuijpers JM, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J. 2017;38(26):2048\u201356.","journal-title":"Eur Heart J"},{"issue":"2","key":"2103_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.115.019307","volume":"134","author":"SM Gilboa","year":"2016","unstructured":"Gilboa SM, et al. Congenital heart defects in the united states: estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101\u20139.","journal-title":"Circulation"},{"issue":"2","key":"2103_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1017\/S1047951122000403","volume":"33","author":"TB Mano","year":"2023","unstructured":"Mano TB, et al. Infective endocarditis in a cohort of adult CHD patients. Cardiol Young. 2023;33(2):190\u20135.","journal-title":"Cardiol Young"},{"key":"2103_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijcard.2022.10.136","volume":"370","author":"JP van Melle","year":"2023","unstructured":"van Melle JP, et al. Infective endocarditis in adult patients with congenital heart disease. Int J Cardiol. 2023;370:178\u201385.","journal-title":"Int J Cardiol"},{"issue":"21","key":"2103_CR6","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.3390\/jcm10215071","volume":"10","author":"M Maser","year":"2021","unstructured":"Maser M, et al. Frequency, mortality, and predictors of adverse outcomes for endocarditis in patients with congenital heart disease: results of a nationwide analysis including 2512 endocarditis cases. J Clin Med. 2021;10(21):5071.","journal-title":"J Clin Med"},{"key":"2103_CR7","first-page":"100141","volume":"4","author":"O Tutarel","year":"2021","unstructured":"Tutarel O. Endocarditis prophylaxis in adult congenital heart disease. Int J Cardiol Congenit Heart Dis. 2021;4:100141.","journal-title":"Int J Cardiol Congenit Heart Dis"},{"issue":"9","key":"2103_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/cid\/ciab533","volume":"73","author":"MM Dagher","year":"2021","unstructured":"Dagher MM, et al. Maternal and fetal outcomes associated with infective endocarditis in pregnancy. Clin Infect Dis. 2021;73(9):1571\u20139.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"2103_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIR.0000000000000298","volume":"132","author":"RS Baltimore","year":"2015","unstructured":"Baltimore RS, et al. Infective endocarditis in childhood: 2015 Update: A scientific statement from the american heart association. Circulation. 2015;132(15):1487\u2013515.","journal-title":"Circulation"},{"issue":"14","key":"2103_CR10","first-page":"e698","volume":"139","author":"KK Stout","year":"2019","unstructured":"Stout KK, et al. 2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2019;139(14):e698\u2013800.","journal-title":"Circulation"},{"issue":"9","key":"2103_CR11","doi-asserted-by":"publisher","first-page":"ofad444","DOI":"10.1093\/ofid\/ofad444","volume":"10","author":"AS Roy","year":"2023","unstructured":"Roy AS, et al. Multidisciplinary teams for the management of infective endocarditis: A systematic review and meta-analysis. Open Forum Infect Dis. 2023;10(9):ofad444.","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 2","key":"2103_CR12","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.21037\/cdt.2019.01.01","volume":"9","author":"S Hollatz","year":"2019","unstructured":"Hollatz S, et al. Awareness of oral health in adults with congenital heart disease. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S281-s291.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8","key":"2103_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/jcm8081255","volume":"8","author":"M Folwaczny","year":"2019","unstructured":"Folwaczny M, et al. Oral Health in Adults with Congenital Heart Disease. J Clin Med. 2019;8(8):1255.","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"2103_CR14","doi-asserted-by":"publisher","first-page":"S377","DOI":"10.21037\/cdt.2018.09.17","volume":"9","author":"M Folwaczny","year":"2019","unstructured":"Folwaczny M, Bauer F, Gr\u00fcnberg C. Significance of oral health in adult patients with congenital heart disease. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S377-s387.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"44","key":"2103_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, et al. ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128.","journal-title":"Eur Heart J"},{"issue":"6","key":"2103_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.21037\/cdt-21-458","volume":"11","author":"N M\u00fcller","year":"2021","unstructured":"M\u00fcller N, et al. \u201cBody modification: piercing and tattooing in congenital heart disease patients\u201d, decoration or disaster?-a narrative review. Cardiovasc Diagn Ther. 2021;11(6):1395\u2013402.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8","key":"2103_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00392-004-0108-y","volume":"93","author":"I D\u00e4hnert","year":"2004","unstructured":"D\u00e4hnert I, Schneider P, Handrick W. Piercing and tattoos in patients with congenital heart disease \u2013 is it a problem? Z Kardiol. 2004;93(8):618\u201323.","journal-title":"Z Kardiol"},{"key":"2103_CR18","unstructured":"Delgado V, et al. ESC Guidelines for the management of endocarditis. Eur Heart J.  2023 Oct 14;44(39):3948\u20134042."},{"issue":"3","key":"2103_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijcard.2008.08.002","volume":"139","author":"DM Tse","year":"2010","unstructured":"Tse DM, Khan S, Clarke S. Bacterial endocarditis and body art: active prevention or antibiotic prophylaxis. Int J Cardiol. 2010;139(3):297\u20138.","journal-title":"Int J Cardiol"},{"issue":"11","key":"2103_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jacc.2022.06.030","volume":"80","author":"MH Thornhill","year":"2022","unstructured":"Thornhill MH, et al. Antibiotic prophylaxis against infective endocarditis before invasive dental procedures. J Am Coll Cardiol. 2022;80(11):1029\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2103_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.adaj.2020.07.021","volume":"151","author":"MH Thornhill","year":"2020","unstructured":"Thornhill MH, et al. Prescribing of antibiotic prophylaxis to prevent infective endocarditis. J Am Dent Assoc. 2020;151(11):835-845.e31.","journal-title":"J Am Dent Assoc"},{"issue":"8","key":"2103_CR22","doi-asserted-by":"publisher","first-page":"e077026","DOI":"10.1136\/bmjopen-2023-077026","volume":"13","author":"SSH Lean","year":"2023","unstructured":"Lean SSH, et al. Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis. BMJ Open. 2023;13(8):e077026.","journal-title":"BMJ Open"},{"issue":"15","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"W Wilson","year":"2007","unstructured":"Wilson W, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the american heart association rheumatic fever, endocarditis, and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116(15):1736\u201354.","journal-title":"Circulation"},{"issue":"15","key":"2103_CR24","first-page":"e523","volume":"118","author":"RO Bonow","year":"2008","unstructured":"Bonow RO, et al. 2008 Focused update incorporated into the ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523-661.","journal-title":"Circulation"},{"issue":"20","key":"2103_CR25","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1161\/CIR.0000000000000969","volume":"143","author":"WR Wilson","year":"2021","unstructured":"Wilson WR, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021;143(20):e963\u201378.","journal-title":"Circulation"},{"issue":"20","key":"2103_CR26","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.116.022047","volume":"134","author":"M Franklin","year":"2016","unstructured":"Franklin M, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation. 2016;134(20):1568\u201378.","journal-title":"Circulation"},{"issue":"5","key":"2103_CR27","first-page":"155","volume":"1","author":"JC Hancox","year":"2013","unstructured":"Hancox JC, et al. Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports. Ther Adv Infect Dis. 2013;1(5):155\u201365.","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"2103_CR28","first-page":"20","volume":"67","author":"AM Bombassaro","year":"2001","unstructured":"Bombassaro AM, Wetmore SJ, John MA. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc. 2001;67(1):20\u20132.","journal-title":"J Can Dent Assoc"},{"issue":"15","key":"2103_CR29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association. Circulation. 2015;132(15):1435\u201386.","journal-title":"Circulation"},{"issue":"1","key":"2103_CR30","first-page":"15","volume":"57","author":"PE Hermans","year":"1982","unstructured":"Hermans PE. The clinical manifestations of infective endocarditis. Mayo Clin Proc. 1982;57(1):15\u201321.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2103_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.lpm.2019.04.002","volume":"48","author":"C Selton-Suty","year":"2019","unstructured":"Selton-Suty C, et al. Complications and prognosis of infective endocarditis. Presse Med. 2019;48(5):532\u20138.","journal-title":"Presse Med"},{"issue":"23","key":"2103_CR32","first-page":"e394","volume":"111","author":"LM Baddour","year":"2005","unstructured":"Baddour LM, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, american heart association: endorsed by the infectious diseases society of america. Circulation. 2005;111(23):e394-434.","journal-title":"Circulation"},{"issue":"4","key":"2103_CR33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/cid\/ciad271","volume":"77","author":"VG Fowler","year":"2023","unstructured":"Fowler VG, et al. The 2023 Duke-ISCVID criteria for infective endocarditis: updating the modified duke criteria. Clin Infect Dis. 2023;77(4):518\u201326. https:\/\/doi.org\/10.1093\/cid\/ciad271.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"2103_CR34","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2018.09.039","volume":"72","author":"DB McElhinney","year":"2018","unstructured":"McElhinney DB, et al. Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2018;72(22):2717\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"2103_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijcard.2017.08.008","volume":"248","author":"MN Pizzi","year":"2017","unstructured":"Pizzi MN, et al. (18)F-FDG-PET\/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material. Int J Cardiol. 2017;248:396\u2013402.","journal-title":"Int J Cardiol"},{"key":"2103_CR36","volume":"47","author":"SC Pereira","year":"2023","unstructured":"Pereira SC, et al. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2023;47: 101249.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"24","key":"2103_CR37","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.jacc.2018.03.534","volume":"71","author":"I Zegri-Reiriz","year":"2018","unstructured":"Zegri-Reiriz I, et al. Infective endocarditis in patients with bicuspid aortic valve or mitral valve prolapse. J Am Coll Cardiol. 2018;71(24):2731\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2103_CR38","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"RO Bonow","year":"1998","unstructured":"Bonow RO, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98(18):1949\u201384.","journal-title":"Circulation"},{"key":"2103_CR39","first-page":"e567","volume":"28","author":"AH Friedlander","year":"2023","unstructured":"Friedlander AH, Couto-Souza PH. Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse. Med Oral Patol Oral Cir Bucal. 2023;28:e567.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"22","key":"2103_CR40","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1136\/heartjnl-2015-309133","volume":"102","author":"E Berglund","year":"2016","unstructured":"Berglund E, et al. High incidence of infective endocarditis in adults with congenital ventricular septal defect. Heart. 2016;102(22):1835\u20139.","journal-title":"Heart"},{"issue":"1","key":"2103_CR41","doi-asserted-by":"publisher","first-page":"e027477","DOI":"10.1161\/JAHA.122.027477","volume":"12","author":"F Eckerstr\u00f6m","year":"2023","unstructured":"Eckerstr\u00f6m F, et al. Lifetime burden of morbidity in patients with isolated congenital ventricular septal defect. J Am Heart Assoc. 2023;12(1):e027477.","journal-title":"J Am Heart Assoc"},{"issue":"36","key":"2103_CR42","doi-asserted-by":"publisher","first-page":"e17044","DOI":"10.1097\/MD.0000000000017044","volume":"98","author":"W Wang","year":"2019","unstructured":"Wang W, et al. Endocarditis and bacterial brain abscess in a young woman with a single atrium, patent ductus arteriosus, and Eisenmenger syndrome: A case report. Medicine (Baltimore). 2019;98(36):e17044.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2103_CR43","first-page":"e32004","volume":"14","author":"OA Mahajan","year":"2022","unstructured":"Mahajan OA, et al. Infective endocarditis in patient with uncorrected patent ductus arteriosus: A case report from rural India. Cureus. 2022;14(11):e32004.","journal-title":"Cureus"},{"issue":"3","key":"2103_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/oxfordjournals.eurheartj.a015272","volume":"18","author":"U Thil\u00e9n","year":"1997","unstructured":"Thil\u00e9n U, Astr\u00f6m-Olsson K. Does the risk of infective endarteritis justify routine patent ductus arteriosus closure? Eur Heart J. 1997;18(3):503\u20136.","journal-title":"Eur Heart J"},{"issue":"4","key":"2103_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/chd.12830","volume":"14","author":"A Callegari","year":"2019","unstructured":"Callegari A, et al. Ductus arteriosus-associated infective endarteritis: Lessons from the past, future perspective. Congenit Heart Dis. 2019;14(4):671\u20137.","journal-title":"Congenit Heart Dis"},{"key":"2103_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2022.09.017","volume":"5","author":"AJ Grewing","year":"2023","unstructured":"Grewing AJ, Furtun BY, Webb MK. Utility of computed tomography in diagnosis of a patent ductus arteriosus in pulmonary artery endarteritis. JACC Case Rep. 2023;5: 101649.","journal-title":"JACC Case Rep"},{"issue":"9","key":"2103_CR47","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/RLU.0000000000004296","volume":"47","author":"T Miyagami","year":"2022","unstructured":"Miyagami T, et al. A case of infective endocarditis associated with patent ductus arteriosus in Which PET\/CT was useful for diagnosis. Clin Nucl Med. 2022;47(9):832\u20133.","journal-title":"Clin Nucl Med"},{"issue":"22","key":"2103_CR48","doi-asserted-by":"publisher","first-page":"e022445","DOI":"10.1161\/JAHA.121.022445","volume":"10","author":"E Havers-Borgersen","year":"2021","unstructured":"Havers-Borgersen E, et al. Incidence of infective endocarditis among patients with tetralogy of fallot. J Am Heart Assoc. 2021;10(22):e022445.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2103_CR49","first-page":"721","volume":"35","author":"AC Egbe","year":"2019","unstructured":"Egbe AC, et al. Trends and outcomes of infective endocarditis in adults with tetralogy of fallot: a review of the national inpatient sample database. Can J Cardiol. 2019;35(6):721\u20136.","journal-title":"Can J Cardiol"},{"issue":"1","key":"2103_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1017\/S1047951119001975","volume":"30","author":"AC Egbe","year":"2020","unstructured":"Egbe AC, et al. Incidence and outcomes of prosthetic valve endocarditis in adults with tetralogy of Fallot. Cardiol Young. 2020;30(1):19\u201323.","journal-title":"Cardiol Young"},{"key":"2103_CR51","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/eurjpc\/zwad260","volume":"31","author":"C Montanaro","year":"2023","unstructured":"Montanaro C, et al. The fontan- infective endocarditis paradox: should patients with a fontan circulation be counselled for antibiotic prophylaxis? Eur J Prev Cardiol. 2023;31:e47.","journal-title":"Eur J Prev Cardiol"},{"issue":"27","key":"2103_CR52","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/eurheartj\/ehz201","volume":"40","author":"J Nordmeyer","year":"2019","unstructured":"Nordmeyer J, et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255\u201364.","journal-title":"Eur Heart J"},{"issue":"16","key":"2103_CR53","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jcin.2019.03.037","volume":"12","author":"S Georgiev","year":"2019","unstructured":"Georgiev S, et al. A low residual pressure gradient yields excellent long-term outcome after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv. 2019;12(16):1594\u2013603.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2103_CR54","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCINTERVENTIONS.112.000087","volume":"6","author":"DB McElhinney","year":"2013","unstructured":"McElhinney DB, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292\u2013300.","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"2103_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.acvd.2014.09.003","volume":"108","author":"S Malekzadeh-Milani","year":"2015","unstructured":"Malekzadeh-Milani S, et al. Incidence and predictors of Melody(R) valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108(2):97\u2013106.","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"2103_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1017\/S1047951116000494","volume":"27","author":"C O'Donnell","year":"2017","unstructured":"O\u2019Donnell C, et al. Infective endocarditis following Melody valve implantation: comparison with a surgical cohort. Cardiol Young. 2017;27(2):294\u2013301.","journal-title":"Cardiol Young"},{"issue":"5","key":"2103_CR57","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jcin.2016.12.012","volume":"10","author":"S Hascoet","year":"2017","unstructured":"Hascoet S, et al. Infective endocarditis risk after percutaneous pulmonary valve implantation with the melody and sapien valves. JACC Cardiovasc Interv. 2017;10(5):510\u20137.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"2103_CR58","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000000458","volume":"135","author":"MM Canobbio","year":"2017","unstructured":"Canobbio MM, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American heart association. Circulation. 2017;135(8):e50\u201387.","journal-title":"Circulation"},{"issue":"11","key":"2103_CR59","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/01.SMJ.0000054503.18393.1E","volume":"96","author":"ME Montoya","year":"2003","unstructured":"Montoya ME, Karnath BM, Ahmad M. Endocarditis during pregnancy. South Med J. 2003;96(11):1156\u20137.","journal-title":"South Med J"},{"issue":"34","key":"2103_CR60","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241.","journal-title":"Eur Heart J"},{"issue":"23","key":"2103_CR61","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.jacc.2008.10.001","volume":"52","author":"CA Warnes","year":"2008","unstructured":"Warnes CA, et al. ACC\/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143\u2013263.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2103_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2214\/AJR.10.5666","volume":"197","author":"ET Hoey","year":"2011","unstructured":"Hoey ET, et al. Cardiovascular MRI for assessment of infectious and inflammatory conditions of the heart. AJR Am J Roentgenol. 2011;197(1):103\u201312.","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2103_CR63","doi-asserted-by":"publisher","first-page":"e024401","DOI":"10.1161\/JAHA.121.024401","volume":"11","author":"R Musleh","year":"2022","unstructured":"Musleh R, et al. Surgical timing in patients with infective endocarditis and with intracranial hemorrhage: A systematic review and meta-analysis. J Am Heart Assoc. 2022;11(10):e024401.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2103_CR64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.109.192665","volume":"121","author":"LM Baddour","year":"2010","unstructured":"Baddour LM, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458\u201377.","journal-title":"Circulation"},{"issue":"15","key":"2103_CR65","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.3390\/jcm12154941","volume":"12","author":"M Dardari","year":"2023","unstructured":"Dardari M, et al. Infective endocarditis among pediatric patients with prosthetic valves and cardiac devices: a review and update of recent emerging diagnostic and management strategies. J Clin Med. 2023;12(15):4941.","journal-title":"J Clin Med"},{"issue":"6","key":"2103_CR66","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/00015385.2020.1761594","volume":"76","author":"L Lakkas","year":"2021","unstructured":"Lakkas L, et al. Infection of cardiac prosthetic valves and implantable electronic devices: early diagnosis and treatment. Acta Cardiol. 2021;76(6):569\u201375.","journal-title":"Acta Cardiol"},{"issue":"Suppl B","key":"2103_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/eurheartj\/16.suppl_B.72","volume":"16","author":"JM Besnier","year":"1995","unstructured":"Besnier JM, Choutet P. Medical treatment of infective endocarditis: general principles. Eur Heart J. 1995;16(Suppl B):72\u20134.","journal-title":"Eur Heart J"},{"issue":"17","key":"2103_CR68","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/eurheartj\/ehab898","volume":"43","author":"A Wang","year":"2022","unstructured":"Wang A, Fosb\u00f8l EL. Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines. Eur Heart J. 2022;43(17):1617\u201325.","journal-title":"Eur Heart J"},{"issue":"29","key":"2103_CR69","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1093\/eurheartj\/ehac234","volume":"43","author":"GJ van Steenbergen","year":"2022","unstructured":"van Steenbergen GJ, et al. Timing of cardiac surgery during pregnancy: a patient-level meta-analysis. Eur Heart J. 2022;43(29):2801\u201311.","journal-title":"Eur Heart J"},{"issue":"26","key":"2103_CR70","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1056\/NEJMoa1112843","volume":"366","author":"DH Kang","year":"2012","unstructured":"Kang DH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466\u201373.","journal-title":"N Engl J Med"},{"issue":"6","key":"2103_CR71","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jtcvs.2016.09.093","volume":"153","author":"GB Pettersson","year":"2017","unstructured":"Pettersson GB, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258.e29.","journal-title":"J Thorac Cardiovasc Surg"}],"updated-by":[{"DOI":"10.1007\/s11886-025-02268-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000}}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02103-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:26:21Z","timestamp":1757118381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02103-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02103-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11886-025-02268-x","asserted-by":"object"}]},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"12 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to reflect the correct surname of the fifth author. 'Whiltlow' should be corrected to 'Whitlow'.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11886-025-02268-x","URL":"https:\/\/doi.org\/10.1007\/s11886-025-02268-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}